Positive results from early trial of drug that could protect brain cells
Date
News
Date
A survey of over 4,000 people with long-term conditions, including those with Parkinson’s, on prescription charges, has found the charge is a barrier to accessing medicine.
Date
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
Date
A brief analysis of what the Health and Disability White Paper means for people with Parkinson's.
Date
On 15 March, chancellor Jeremy Hunt set out the government’s economic plans. Here’s our summary of the measures announced and their potential impact on people with Parkinson’s and their carers.
Date
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson’s symptoms.
Date
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
Date
Parkinson’s UK brought health leaders, clinicians, people with Parkinson’s and care partners together to discuss key challenges and solutions facing the Parkinson’s healthcare workforce.
Date
Reach Your Peak will use the new physical activity grant funding to subsidise their online fitness and wellbeing sessions for the Parkinson's community.
Date
From 1 February 2023 all Co-beneldopa products, including Madopar, will be provided in pack sizes of 100 only.
Date
NICE has conditionally recommended 5 remote monitoring devices for Parkinson’s for use in the NHS in England.